Cargando...
Barriers to Oncology Biosimilars Uptake in the United States
Biosimilars are biological compounds that contain an active substance that is similar to the active substance in an already approved biologic. This commentary focuses on the barriers to the use of biosimilars in the United States.
Gardado en:
| Publicado en: | Oncologist |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AlphaMed Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6291332/ https://ncbi.nlm.nih.gov/pubmed/30049886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0066 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|